INNATE PHARMA revenue breakdown overview

INNATE PHARMA revenue for the last year amounted to 61.64 M EUR, the most of which — 61.64 M EUR — came from its highest performing source at the moment, Research and Development of Pharmaceutical Products, the year earlier bringing 57.67 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought INNATE PHARMA 61.64 M EUR, and the year before that — 57.67 M EUR.